FDA Webinar: Draft Guidance For Industry On Alzheimer’s Disease: Developing Drugs For The Treatment Of Early Stage Disease; Availability - March 28, 2013
On March 28, 2013, FDA presented a webinar on a new draft guidance entitled "Draft Guidance For Industry On Alzheimer’s Disease: Developing Drugs For The Treatment Of Early Stage Disease; Availability."
The webinar provided an opportunity to learn about the guidance from individuals involved in its preparation. It is also intended to encourage the submission of questions or comments while the guidance is still in draft form.
Questions were submitted online during the webinar and were addressed as time permitted. All questions should also be submitted to docket so that they can be formally processed by FDA.
View Presentation Here: https://collaboration.fda.gov/p73232265
Download Presentation Slides: Developing Drugs For The Treatment Of Early Stage Disease (PDF – 481KB)
FR NOTICE
Date Published: 02/08/2013
Deadline for Comments: 04/09/2013
Contact: Nicholas A. Kozauer
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Ave.
Bldg. 22, Rm. 4351
Silver Spring, MD 20993–0002
301–796–2250
SPEAKER:
Russell G. Katz, MD
Director, Division of Neurology Products
CDER/FDA
(301) 796-2250
Archive of Past Webinars:
If you have never attended a Connect Pro meeting before, please test your connection before the lecture by following this link: https://collaboration.fda.gov/common/help/en/support/meeting_test.htm